RxSight, Inc. logo RXST - RxSight, Inc.

NEXT EARNINGS: Feb 25, 2026 (today) EPS Est: $-0.23 | Rev Est: $32.6M
Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 3
HOLD 7
SELL 2
STRONG
SELL
0
| PRICE TARGET: $10.33 DETAILS
HIGH: $11.00
LOW: $10.00
MEDIAN: $10.00
CONSENSUS: $10.33
UPSIDE: 15.55%
Market Cap: 367.58M
Volume: 418,621
Avg Volume: 975,721
52 Week Range: 6.32-29.785
Sector: Healthcare
Industry: Medical - Devices
Beta: 1.13
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 498
IPO Date: 2021-07-30
EPS (TTM): -0.71
P/E Ratio: -48.67
Revenue (TTM): 139.93M
Total Assets: 318.56M
Total Debt: 12.30M
Cash & Equiv: 16.71M
Rev Growth (5Y): 128.5%
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -9.4%
Debt/Equity: 0.04

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-05 $-0.04 $-0.19 +78.9% $30.3M $32.6M -6.9%
2025-08-07 $-0.08 $-0.10 +20.0% $33.6M $25.7M +30.6%
2025-05-07 $-0.03 $-0.04 +25.0% $37.9M $37.9M 0.0%
2025-02-25 $0.03 $0.10 -70.0% $40.2M $39.8M +1.1%
2024-11-07 $-0.16 $-0.25 +36.0% $45.4M $40.4M +12.5%
2024-08-05 $-0.16 $-0.22 +27.3% $34.9M $35.0M -0.4%
2024-05-06 $-0.12 $-0.17 +29.4% $29.5M $27.6M +7.1%
2024-02-28 $-0.26 $-0.36 +27.8% $28.6M $27.4M +4.2%

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019
Revenue 139.93M 89.08M 49.01M 22.59M 14.68M 2.24M
Net Income (27.45M) (48.61M) (66.76M) (48.69M) 27.57M 126.22M
EPS -0.71 -1.41 -2.41 -1.78 0.18 0.95
Total Assets 318.56M 182.55M 150.16M 192.72M 100.68M 110.43M
Total Debt 12.30M 3.01M 44.99M 44.93M 30.75M 5.52M
Cash & Equivalents 16.71M 9.69M 11.83M 24.36M 13.99M 7.96M
Operating Cash Flow (16.95M) (41.59M) (58.85M) (44.71M) (35.20M) (40.62M)
Free Cash Flow (22.39M) (46.41M) (61.24M) (46.65M) (37.74M) (44.70M)
FCF per Share -0.58 -1.35 -2.21 -1.70 -1.98 -2.34
Book Value 281.24M 160.36M 89.90M 138.24M (297.53M) (304.61M)
Cash & ST Investments 237.22M 127.18M 105.80M 159.33M 68.97M 80.67M
ROC Equity -0.10 -0.30 -0.74 -0.35 N/A N/A